Would you make yourself sick for science?
Saved in:
| Title: | Would you make yourself sick for science? |
|---|---|
| Authors: | Adam, David (AUTHOR) |
| Source: | New Scientist. 12/6/2025, Vol. 268 Issue 3572, p38-41. 4p. 4 Color Photographs. |
| Subjects: | Vaccine development, COVID-19 pandemic, Immune response, Medical research, Ethical problems, Volunteer service |
| Geographic Terms: | Belgium |
| Abstract: | The article focuses on the practice of human challenge trials, where healthy volunteers intentionally become infected with diseases to aid in vaccine development and understand immune responses. Vaccinopolis, a facility in Antwerp, Belgium, is dedicated to conducting these trials, which have gained renewed interest due to the urgency created by the COVID-19 pandemic. These trials allow researchers to quickly assess vaccine efficacy and track disease progression in controlled environments, although ethical concerns remain regarding the risks to participants. The article highlights the motivations of volunteers, such as altruism and financial compensation, while also addressing the historical context and potential benefits of this research approach. [Extracted from the article] |
| Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 189744329 AccessLevel: 6 PubType: Periodical PubTypeId: serialPeriodical PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Would you make yourself sick for science? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Adam%2C+David%22">Adam, David</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22New+Scientist%22">New Scientist</searchLink>. 12/6/2025, Vol. 268 Issue 3572, p38-41. 4p. 4 Color Photographs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Vaccine+development%22">Vaccine development</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+pandemic%22">COVID-19 pandemic</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+response%22">Immune response</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+research%22">Medical research</searchLink><br /><searchLink fieldCode="DE" term="%22Ethical+problems%22">Ethical problems</searchLink><br /><searchLink fieldCode="DE" term="%22Volunteer+service%22">Volunteer service</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Belgium%22">Belgium</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The article focuses on the practice of human challenge trials, where healthy volunteers intentionally become infected with diseases to aid in vaccine development and understand immune responses. Vaccinopolis, a facility in Antwerp, Belgium, is dedicated to conducting these trials, which have gained renewed interest due to the urgency created by the COVID-19 pandemic. These trials allow researchers to quickly assess vaccine efficacy and track disease progression in controlled environments, although ethical concerns remain regarding the risks to participants. The article highlights the motivations of volunteers, such as altruism and financial compensation, while also addressing the historical context and potential benefits of this research approach. [Extracted from the article] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=189744329 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 4 StartPage: 38 Subjects: – SubjectFull: Vaccine development Type: general – SubjectFull: COVID-19 pandemic Type: general – SubjectFull: Immune response Type: general – SubjectFull: Medical research Type: general – SubjectFull: Ethical problems Type: general – SubjectFull: Volunteer service Type: general – SubjectFull: Belgium Type: general Titles: – TitleFull: Would you make yourself sick for science? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Adam, David IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 12 Text: 12/6/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 02624079 Numbering: – Type: volume Value: 268 – Type: issue Value: 3572 Titles: – TitleFull: New Scientist Type: main |
| ResultId | 1 |
